COUR vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

COUR

57.8
AI Score
VS
COUR Wins

UTI

53.0
AI Score

Investment Advisor Scores

COUR

58score
Recommendation
HOLD

UTI

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric COUR UTI Winner
Forward P/E 11.236 47.1698 COUR
PEG Ratio 0 3.1448 Tie
Revenue Growth 9.1% 6.7% COUR
Earnings Growth 0.0% -96.3% COUR
Tradestie Score 57.8/100 53.0/100 COUR
Profit Margin -8.2% 4.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

COUR 1M: -11.2% · 3M: -10.8% UTI 1M: -16.4% · 3M: +4.7%

Current Technical Phase

COUR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 44

RSI (14): 44.0 · Price: $5.31

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $39.31

Fundamentals Snapshot

Metric COUR UTI
Market Cap
Forward P/E 6.3 46.2
Trailing P/E 54.1
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin -0.1% 0.0%
EPS -0.32 0.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, COUR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.